Skip Navigation

JNCI Journal of the National Cancer Institute 2002 94(2):86-87;
© 2002 by Oxford University Press
This Article
Right arrow Extract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 94, No. 2, 86-87, January 16, 2002
© 2002 Oxford University Press

NEWS

Awards, Appointments, Announcements

Richard D. Klausner, M.D., former director of the National Cancer Institute, was appointed senior fellow and special adviser for counterterrorism to the presidents of the National Academies.

Klausner will serve as the liaison for counterterrorism efforts between the White House Office of Science and Technology Policy and the National Academies.

Klausner was previously president of the recently dissolved Case Institute of Health, Science, and Technology, a foundation that intended to focus on multidisciplinary solutions to science and health problems. He will continue to run his laboratory at NCI.

Thurn to Head Review Program

Anne Thurn, M.D., has been appointed director of the evidence-based review program in the Office of Dietary Supplements at NIH. Thurn was previously the associate director of the Cancer Information Products and Systems at NCI.

Thurn’s achievements include making enhancements to the Physician Data Query clinical trials database and CancerNet. She has also helped to redesign NCI’s Web site, cancer.gov.

Sarosy Named

Gisele A. Sarosy, M.D., a medical oncologist, has been named acting director of the Cancer Information Products Systems at NCI. She will be replacing Anne Thurn, M.D., who will head NIH’s Office of Dietary Supplements.

Prior to Sarosy’s appointment, she was the deputy director of the Cancer Information Products Systems.

Feigal Appointed

Ellen Feigal, M.D., has been appointed acting director of the Division of Cancer Treatment and Diagnosis at NCI. She was previously deputy director of DCTD.

Feigal has also been part of the NCI’s Cancer Therapy Evaluation Program. Her achievements include helping to create the national AIDS Malignancy Consortium, and the AIDS and Cancer Specimen Bank.

Wittes Named Physician-in-Chief

Robert Wittes, M.D., has been appointed physician-in-chief at the Memorial Sloan-Kettering Cancer Center, New York.

Wittes was previously NCI’s deputy director for extramural science. He is a former editor of the Journal of the National Cancer Institute.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Extract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?